{"id":"W2979498219","doi":"10.1182/blood.v116.21.428.428","title":"A Phase 2, Double-Blind, Placebo-Controlled Trial of Rituximab + Galiximab Vs Rituximab + Placebo In Advanced Follicular Non-Hodgkin's Lymphoma (NHL)","year":2010,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Rituximab; Medicine; Follicular lymphoma; Internal medicine; Lymphoma; Clinical endpoint; Phases of clinical research; Oncology; Chemotherapy regimen; CD20; Immunology; Gastroenterology; Chemotherapy; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002122133,0.00214156,0.004298223,0.000563722,0.0005555273,0.001164731,0.001307048,0.00250673,0.00786535],"category_scores_gemma":[0.00200431,0.0009276117,0.001544948,0.0004213686,0.001454266,0.001286299,0.0004429416,0.003312418,0.001471946],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007091921,"about_ca_system_score_gemma":0.001184473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006992519,"about_ca_topic_score_gemma":0.001426185,"domain_scores_codex":[0.9991294,0.0004884008,0.00004716573,0.0001529284,0.00005333661,0.0001288268],"domain_scores_gemma":[0.9989592,0.0003447143,0.000205939,0.00008997857,0.00008127135,0.0003189908],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9855255,0.006962176,0.000145226,0.0002884334,0.0003032197,0.00001978312,0.00002413573,0.00009758009,0.001610012,0.0000409699,0.0003076073,0.004675336],"study_design_scores_gemma":[0.9547654,0.04415792,0.0004294432,0.00001190087,0.0001227454,0.00001015784,0.000007821897,0.0001366749,0.0001309035,0.00005510601,0.0001662696,0.00000572157],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9825107,0.004056016,0.0007131976,0.0007675674,0.001148514,0.007478618,0.00112982,0.0001977033,0.001997813],"genre_scores_gemma":[0.9741492,0.002543853,0.002025106,0.001755405,0.001032404,0.01322424,0.001150542,0.00003476212,0.004084589],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00786535,"threshold_uncertainty_score":0.02631217,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01347926879951231,"score_gpt":0.2974226006312746,"score_spread":0.2839433318317622,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}